Journal for ImmunoTherapy of Cancer (Nov 2023)

132 A quantitative mass spectrometry workflow for highly multiplexed measurement of immunomodulatory proteins to support immunotherapy clinical trials

Luca Genovesi,
Michael Schirm,
Gwenaël Pottiez,
Nicholas Dupuis,
Anne Jang,
Ons Ousji,
Timon Geib

Affiliations

Luca Genovesi: CelCarta, Montreal, QC, Canada
Michael Schirm: Caprion Biosciences, Montreal, Canada
Gwenaël Pottiez: CelCarta, Montreal, QC, Canada
Nicholas Dupuis: CelCarta, Montreal, QC, Canada
Anne Jang: CelCarta, Montreal, QC, Canada
Ons Ousji: CelCarta, Montreal, QC, Canada
Timon Geib: CelCarta, Montreal, QC, Canada

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0132
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal